Clinical Trial Update: A Clinical Study of the CardiAQ™ TMVI System (Transapical DS) [NA]

View source ↗

Summary

Edwards Lifesciences reports that the CardiAQ TMVI System (Transapical DS) clinical study has been terminated. The trial focused on treating mitral valve diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Insufficiency
• Valvular Heart Disease

Drugs mentioned

• CardiAQ TMVI System (Transapical DS)

Snippet

Sponsor: Edwards Lifesciences | Conditions: Mitral Insufficiency, Heart Valve Disease | NA | Status: TERMINATED